Biopharmaceuticals - GSK pays big for late-stage cancer drug

被引:0
|
作者
Jarvis, Lisa
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
  • [31] Late-Stage Functionalization and its Impact on Modern Drug Discovery
    Nippa, David F.
    Hohler, Remo
    Stepan, Antonia F.
    Grether, Uwe
    Konrad, David B.
    Martin, Rainer E.
    CHIMIA, 2022, 76 (03) : 258 - 260
  • [32] SuFEx click chemistry enabled late-stage drug functionalization
    Liu, Zilei
    Li, Jie
    Li, Suhua
    Li, Gencheng
    Sharpless, Karl
    Wu, Peng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [33] Late-Stage Sulfoximination: Improved Synthesis of the Anticancer Drug CandidateAtuveciclib
    Glachet, Thomas
    Franck, Xavier
    Reboul, Vincent
    SYNTHESIS-STUTTGART, 2019, 51 (04): : 971 - 975
  • [34] A review of late-stage CNS drug candidates for the treatment of obesity
    Heal, D. J.
    Gosden, J.
    Smith, S. L.
    INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 (01) : 107 - 117
  • [35] A review of late-stage CNS drug candidates for the treatment of obesity
    D J Heal
    J Gosden
    S L Smith
    International Journal of Obesity, 2013, 37 : 107 - 117
  • [36] EFFECT OF TREATMENTS FOR LATE-STAGE PROSTATE CANCER ON SURVIVAL
    Ali, A. A.
    Xiao, H.
    Adunlin, G. B.
    VALUE IN HEALTH, 2012, 15 (04) : A211 - A212
  • [37] Clinical and demographic predictors of late-stage cervical cancer
    Ferrante, JM
    Gonzalez, EC
    Roetzheim, RG
    Pal, N
    Woodard, L
    ARCHIVES OF FAMILY MEDICINE, 2000, 9 (05) : 439 - 445
  • [38] Etirinotecan pegol: an option for late-stage breast cancer?
    Nielsen, Dorte L.
    Brunner, Nils
    LANCET ONCOLOGY, 2013, 14 (12): : 1149 - 1151
  • [39] NCI begins overhaul of late-stage cancer trials
    Alicia Ault
    Nature Medicine, 1998, 4 : 1219 - 1219
  • [40] NCI begins overhaul of late-stage cancer trials
    Ault, A
    NATURE MEDICINE, 1998, 4 (11) : 1219 - 1219